The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27240464 |
24 |
Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. |
Academia Sinica |
21470860 |
9 |
Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation. |
Chonnam National University |
19625187 |
22 |
Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives. |
Konkuk University |
19233643 |
16 |
Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase. |
Konkuk University |
24332657 |
35 |
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings. |
University of Illinois At Chicago |
24316352 |
27 |
Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors. |
Tianjin University of Science and Technology |
24125888 |
2 |
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. |
Kansas State University |
23647823 |
27 |
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. |
Korea Research Institute of Bioscience and Biotechnology |
23202846 |
4 |
Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases. |
The Chinese University of Hong Kong |
20947359 |
18 |
Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors. |
Academia Sinica |
20934345 |
20 |
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. |
Korea Research Institute of Bioscience and Biotechnology |
20167482 |
10 |
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. |
Korea Research Institute of Bioscience and Biotechnology |
19540764 |
1 |
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death. |
National Human Genome Research Institute |
19362479 |
15 |
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors. |
Kyoto Pharmaceutical University |
17709464 |
8 |
Novel small-molecule inhibitors of transmissible gastroenteritis virus. |
National Health Research Institute |
17855091 |
7 |
Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors. |
Purdue University |
29544147 |
36 |
Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. |
Wichita State University |
9884068 |
18 |
Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors. |
Smithkline Beecham Pharmaceuticals |
19278250 |
64 |
A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408). |
Wyeth Research |
19256503 |
32 |
Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode. |
Boehringer Ingelheim Pharmaceuticals |
19226143 |
17 |
Exploiting the pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors. |
Universita Di Pisa |
19217779 |
15 |
Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitors. |
Amgen |
19296695 |
38 |
Development of a novel virtual screening cascade protocol to identify potential trypanothione reductase inhibitors. |
University of Alberta |